Adent and Khiron Announce Closing of Subscription Receipt Financing
January 16, 2018 11:53 ET
|
Khiron Life Sciences Corp.
Not for distribution to U.S. Newswire Services or for dissemination in the United States. TORONTO, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Further to the press releases dated November 7, 2017, and...
Khiron Receives Cultivation Quota From Colombian Government and Commences Cultivation of Medical Cannabis Strains
December 28, 2017 09:23 ET
|
Khiron Life Sciences Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that the...
Khiron Provides Corporate Update & Revises Financing Terms
December 14, 2017 08:42 ET
|
Khiron Life Sciences Corp.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) is pleased to...
Khiron and Adent Announce Letter of Intent for Proposed Business Combination
October 26, 2017 17:12 ET
|
Khiron Life Sciences Corp.
TORONTO, Oct. 26, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron”) and Adent Capital Corp. ("Adent") (NEX:ANT.H) report that the parties have entered into an arm’s length non-binding...
Khiron First Company to be Fully Licensed for High and Low THC Medical Cannabis in Colombia
October 23, 2017 15:48 ET
|
Khiron Life Sciences Corp.
TORONTO, Oct. 23, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that further to its press release dated September 26, 2017, the Company’s wholly owned...
Khiron Advisor Featured as Part of Joint Investigation by 60 Minutes and the Washington Post on U.S. Opioid Crisis
October 13, 2017 18:45 ET
|
Khiron Life Sciences Corp.
TORONTO, Oct. 13, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that Matthew Murphy, Security and Compliance Advisor to Khiron, and former U.S. DEA Chief of...
Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board
September 29, 2017 11:08 ET
|
Khiron Life Sciences Corp.
TORONTO, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration...
Khiron First Company to Receive Licence for Cultivation of Medical Cannabis in Colombia
September 26, 2017 09:07 ET
|
Khiron Life Sciences Corp.
TORONTO, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence...